The growing demand for precise immunological investigation and therapeutic design has spurred significant improvements in recombinant signal molecule generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently manufactured using various expression platforms, including bacterial hosts, higher cell cultures, and